Analyst upgrades, downgrades and initiations: BA, EXEL, FINL, NTAP, UNH, WU ...


Analyst upgrades:

  • B. Riley upgraded Finish Line (NASDAQ: FINL) to Buy from Neutral to reflect the potential for improving trends in second half of 2009. The firm raised its target on shares to $10.50 from $9.
  • Merriman upgraded OptionXpress (NASDAQ: OXPS) to Neutral from Sell following the company's better than expected Q2 results. The firm notes higher commissions per trade more than offset weak DARTs and the decline in customer additions in the quarter.
  • RBC Capital upgraded Gardner Denver (NYSE: GDI) to Outperform from Sector Perform and raised its target to $34 from $28 citing the additional scale of restructuring, better tone to end-markets, and few downside catalysts. Baird upgraded Gardner Denver to Outperform from Neutral and raised its target to $35 from $32 based on a bottom in fundamentals and compelling valuation.
  • BE Aerospace (NASDAQ: BEAV) was upgraded to Outperform from Market Perform at FBR Capital.
  • Shire (NASDAQ: SHPGY) was upgraded to Perform from Underperform at Oppenheimer.
  • UnitedHealth (NYSE: UNH) was upgraded to Outperform from Neutral at Credit Suisse.

Analyst downgrades:

  • Deutsche Bank downgraded Autodesk (NASDAQ: ADSK) to Hold from Buy on valuation, seeing a balanced risk/reward at current levels. The firm lowered its target on shares to $24 from $25.
  • B. Riley downgraded National Penn Bancshares (NASDAQ: NPBC) to Neutral from Buy following the company's Q2 results. The firm has a $4.50 target on the stock.
  • Barclays downgraded Boeing (NYSE: BA) to Equal Weight from Overweight and lowered its target to $46 from $60 based on delays in the 787.
  • Exelon (NYSE: EXC) was downgraded to Market Perform from Outperform at Wells Fargo.
  • Thompson Creek (NYSE: TC) was downgraded to Sector Underperformer at CIBC.
  • Catalyst Health Solutions (NASDAQ: CHSI) was downgraded to Hold from Buy at BB&T.

Analyst initiations:

  • Citigroup believes Western Union's (NYSE: WU) EPS growth could top expectations and that downside is limited at current valuation levels. Shares were started with a Buy rating and $22 target.
  • Genworth (NYSE: GNW) was initiated with a Hold rating and $40 target at Sandler O'Neill.
  • Exelon (NYSE: EXC) was reinstated with an Equal Weight rating and $61 target at Barclays.
  • NetApp (NASDAQ: NTAP) coverage was resumed with an Equal Weight rating at Morgan Stanley.
  • Seneca Foods (NASDAQ: SENEA) was initiated with an Overweight rating and $30 target at Piper Jaffray.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-135.4712,754.99
NASDAQ-23.832,903.40
S&P 500-12.291,339.66

Last updated: February 10, 2012: 02:03 PM

Hot Stocks

General Electric

18.805-0.325(-1.70)

Alcoa

10.255-0.385(-3.62)

Apple Inc

493.98+0.81(+0.16)

Google Inc 'A'

605.34-6.12(-1.00)

Bank of America

8.065-0.115(-1.41)

Wal-Mart Stores

61.50-0.46(-0.74)

Exxon Mobil Corp

83.51-1.37(-1.61)

Ford

12.44-0.25(-1.97)

Citigroup

32.89-0.77(-2.29)

IBM

191.85-1.28(-0.66)

Yahoo

16.18+0.18(+1.12)

Starbucks

48.65-0.55(-1.12)

Microsoft

30.54-0.23(-0.75)

Home Depot

45.01-0.26(-0.57)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328900589867 ms.